The growth of the global intravenous solutions market is being driven by the rising prevalence of the chronic diseases across the globe. The market value was 12.16 billion in 2022 and it is anticipated to grow at a CAGR of 7.15% during the forecast period of 2023-2031. The global intravenous solutions market is anticipated to achieve a value of USD 22.64 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America, with the bulk of the overall market share, is the dominant market for intravenous solutions. The regional market is being driven by the rapid development of the United States manufacturing capacity owing to a shortage of IV fluids. Moreover, developing countries, including India and China, are increasing their investments in the health sector, which is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.
The development of IV fluids has seen tremendous growth, especially in developed countries. For example, it has been stated that the US Food and Drug Administration (FDA) and other market players are making efforts to alleviate the crisis because of the scarcity of IV saline. In relation to this, Merge, a US-based marketing and development organisation, collaborated with the ground-breaking provider of medical products and services, B. Braun Medical, to launch omnichannel campaign 'Solutions for Life' in May 2020. This programme seeks to ensure an effective supply of IV solutions, approved by the United States FDA.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Intravenous (IV) solutions refer to a complete mixture of vital nutrients intended to refill fluid losses, treat electrolyte imbalances as well as maintain fluid balance in intravenous therapy. It also provides the patients suffering from diabetes, cancer, and other diseases with the necessary nutrients. Intravenous solutions can contain water incorporated in concentrations with electrolytes, sugar, or medicines, as prescribed by the patient. In accordance with this, these solutions differ in rate and quantity, relying on the patient's medical condition, age, as well as body size.
Based on type, the market can be divided into the following:
On the basis of nutrients, the industry can be segmented as follows:
The regional markets for intravenous solutions include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Owing to unhealthy dietary habits, there has been a rise in disease prevalence, including gastrointestinal disorder, neurological disorders, cancer, and diabetes, which is the main factor contributing to the development of the intravenous solutions market. In fact, since these options are available in compact packets, it is safer for patients to use the drips at the convenience of their home rather than hospitals. In addition, developing countries, including India and China, are increasing their investment in the health sector that is likely to boost the demand for intravenous solutions. Additionally, manufacturers are implementing new product technologies like offering premixed options for greater convenience and reducing packaging waste.
The report gives a detailed analysis of the following companies in the global intravenous solutions market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Nutrients||
|Breakup by Bag Type||
|Breakup by Application||
|Breakup by End User||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intravenous Solutions Market Overview
3.1 Global Intravenous Solutions Market Historical Value (2016-2022)
3.2 Global Intravenous Solutions Market Forecast Value (2023-2031)
4 Global Intravenous Solutions Market Landscape
4.1 Global Intravenous Solutions Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intravenous Solutions Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Nutrients
4.2.3 Analysis by Bag Type
4.2.4 Analysis by Applications
4.2.5 Analysis by End User
5 Global Intravenous Solutions Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intravenous Solutions Market Segmentation
6.1 Global Intravenous Solutions Market by Type
6.1.1 Market Overview
6.1.2 Partial Parenteral Nutrition
6.1.3 Total Parenteral Nutrition
6.2 Global Intravenous Solutions Market by Nutrients
6.2.1 Market Overview
6.2.3 Salts and Electrolytes
6.2.6 Amino Acids
6.3 Global Intravenous Solutions Market by Bag Type
6.3.1 Market Overview
6.3.2 Large Volume Bags (>250 mL)
6.3.3 Small Volume Bags (<250 mL)
6.4 Global Intravenous Solutions Market by Application
6.4.1 Market Overview
6.4.2 Basic IV Solution
6.4.3 Nutritional IV Solution
6.4.4 Blood IV Solution
6.4.5 Drug IV Solution
6.4.6 Irrigation IV Solution
6.5 Global Intravenous Solutions Market by End User
6.5.1 Market Overview
6.5.4 Ambulatory Surgical Centres
6.5.5 Homecare Settings
6.6 Global Intravenous Solutions Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Intravenous Solutions Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Intravenous Solutions Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Intravenous Solutions Market
9.1 Market Share by Country
10 Latin America Intravenous Solutions Market
10.1 Market Share by Country
11 Middle East and Africa Intravenous Solutions Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Ajinomoto Health & Nutrition North America, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 B. Braun Medical Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 ICU Medical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Baxter International, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Fresenius Kabi AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Pfizer inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Otsuka Pharmaceutical Co., Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Vifor Pharma Management Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 JW Life Science
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Amanta Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Grifols, S.A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
18 Global Intravenous Solutions Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2022, the global intravenous solutions market attained a value of nearly USD 9.73 billion.
The market is projected to grow at a CAGR of 6% between 2023 and 2031.
The market is estimated to witness a healthy growth in the forecast period of 2023-2031 to reach about USD 16.5 billion by 2031.
The major drivers of the industry, such as unhealthy dietary habits, disease prevalence, including gastrointestinal disorder, neurological disorders, cancer and diabetes, and increasing investments in the health sector, are expected to aid the market growth.
The key market trends guiding the growth of the intravenous solutions market include the launch of new product technologies that offer premixed options for greater convenience and reducing packaging waste.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The major types of intravenous solutions in the industry are partial parenteral nutrition and total parenteral nutrition.
The leading nutrients of intravenous solutions are carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.
The major players in the industry are Ajinomoto Health & Nutrition North America, Inc., B. Braun Medical Inc., ICU Medical, Inc., and Baxter International, Inc., among others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.